PRESS RELEASES

Date	Title and Summary	Additional Formats
Toggle SummaryOct 18, 2004	Integra LifeSciences Announces CE Mark for DuraGen Plus Adhesion Barrier Matrix Integra LifeSciences Announces CE Mark for DuraGen Plus(TM) Adhesion Barrier Matrix PLAINSBORO, N.J., Oct. 18, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has received CE Mark Certification for the DuraGen Plus™ Adhesion Barrier Matrix.	View HTML Integra LifeSciences Announces CE Mark for DuraGen Plus(TM) Adhesion Barrier Matrix 12.2 KB
Toggle SummaryOct 18, 2004	Integra LifeSciences and University of Pennsylvania to Present Results of Brain Tissue Oxygen Monitoring Clinical Experience at 2004 Congress of Neurological Surgeons Annual Meeting in San Francisco Integra LifeSciences and University of Pennsylvania to Present Results of Brain Tissue Oxygen Monitoring Clinical Experience at 2004 Congress of Neurological Surgeons Annual Meeting in San Francisco PLAINSBORO, N.J., Oct. 18, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation	View HTML Integra LifeSciences and University of Pennsylvania to Present Results of Brain Tissue Oxygen Monitoring Clinical Experience at 2004 Congress of Neurological Surgeons Annual Meeting in San Francisco 12.2 KB
Toggle SummaryOct 15, 2004	Integra NeuroSciences Launches NeuroSensor Cerebral Blood Flow and Intracranial Pressure System Integra NeuroSciences Launches NeuroSensor Cerebral Blood Flow and Intracranial Pressure System PLAINSBORO, N.J., Oct. 15, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it plans to market and sell the NeuroSensor Cerebral Blood Flow and	View HTML Integra NeuroSciences Launches NeuroSensor Cerebral Blood Flow and Intracranial Pressure System 11.7 KB
Toggle SummaryOct 15, 2004	Integra NeuroSciences Launches NPH Low Flow Hydrocephalus Valve Integra NeuroSciences Launches NPH(TM) Low Flow Hydrocephalus Valve PLAINSBORO, N.J., Oct. 15, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced plans to market and sell the NPH™ Low Flow Hydrocephalus Valve (NPH™ Valve) through its direct Integra	View HTML Integra NeuroSciences Launches NPH(TM) Low Flow Hydrocephalus Valve 11.7 KB
Toggle SummaryOct 12, 2004	Integra LifeSciences Launches INTEGRA Matrix Wound Dressing at Plastic Surgery 2004 in Philadelphia Integra LifeSciences Launches INTEGRA(TM) Matrix Wound Dressing at Plastic Surgery 2004 in Philadelphia PLAINSBORO, N.J., Oct. 12, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the launch of the INTEGRA™ Matrix Wound Dressing, a single layer version of	View HTML Integra LifeSciences Launches INTEGRA(TM) Matrix Wound Dressing at Plastic Surgery 2004 in Philadelphia 11.5 KB
Toggle SummaryOct 11, 2004	Integra LifeSciences Receives FDA Approval and CE Mark for INTEGRA® Dermal Regeneration Template - Terminally Sterilized Integra LifeSciences Receives FDA Approval and CE Mark for INTEGRA(R) Dermal Regeneration Template - Terminally Sterilized PLAINSBORO, N.J., Oct. 11, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that Integra LifeSciences has received approval from the	View HTML Integra LifeSciences Receives FDA Approval and CE Mark for INTEGRA(R) Dermal Regeneration Template - Terminally Sterilized 12.8 KB
Toggle SummaryOct 8, 2004	Integra LifeSciences Launches New Web Site For Physician Information and Training Integra LifeSciences Launches New Web Site For Physician Information and Training PLAINSBORO, N.J., Oct. 8, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has launched a new website for physicians that provides information and training on the use	View HTML Integra LifeSciences Launches New Web Site For Physician Information and Training 12.8 KB
Toggle SummaryOct 1, 2004	Integra LifeSciences Announces Neuromonitoring Strategic Alliance with CNS Technology, LLC and Moberg Research, Inc. Integra LifeSciences Announces Neuromonitoring Strategic Alliance with CNS Technology, LLC and Moberg Research, Inc. PLAINSBORO, N.J., Oct. 1, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has entered into a development agreement pursuant to	View HTML Integra LifeSciences Announces Neuromonitoring Strategic Alliance with CNS Technology, LLC and Moberg Research, Inc. 12 KB
Toggle SummaryOct 1, 2004	Integra LifeSciences Announces Achievement of Product Development Milestone by Novus Monitoring Limited Integra LifeSciences Announces Achievement of Product Development Milestone by Novus Monitoring Limited PLAINSBORO, N.J., Oct. 1, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it paid $1.4 million to Novus Monitoring Limited for the achievement of	View HTML Integra LifeSciences Announces Achievement of Product Development Milestone by Novus Monitoring Limited 12 KB
Toggle SummarySep 28, 2004	District Court Awards Integra LifeSciences $6.37 Million in Damages District Court Awards Integra LifeSciences $6.37 Million in Damages PLAINSBORO, N.J., Sept. 28, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that the United States District Court for the Southern District of California, ruling in the case Integra	View HTML District Court Awards Integra LifeSciences $6.37 Million in Damages 10.7 KB
Toggle SummarySep 8, 2004	Integra NeuroSciences Launches NeuraWrap Nerve Protector Integra NeuroSciences Launches NeuraWrap(TM) Nerve Protector PLAINSBORO, N.J., Sept. 8, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that Integra NeuroSciences has received 510(k) clearance from the United States Food and Drug Administration to market	View HTML Integra NeuroSciences Launches NeuraWrap(TM) Nerve Protector 11.5 KB
Toggle SummaryJul 27, 2004	Integra LifeSciences Announces Second Quarter 2004 Financial Results Integra LifeSciences Announces Second Quarter 2004 Financial Results PLAINSBORO, N.J., July 27, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported net income of $7.5 million, or $0.24 per share, for the second quarter of 2004, compared to net income of $5.4	View HTML Integra LifeSciences Announces Second Quarter 2004 Financial Results 14.5 KB
Toggle SummaryJul 27, 2004	Integra LifeSciences Launches KraniOS Cranial Closure System Integra LifeSciences Launches KraniOS(TM) Cranial Closure System PLAINSBORO, N.J., July 27, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it plans to market and sell the KraniOS™ Cranial Closure System, a complete set of implants and tools	View HTML Integra LifeSciences Launches KraniOS(TM) Cranial Closure System 14.5 KB
Toggle SummaryJul 27, 2004	Integra LifeSciences Extends Employment Agreement of Chief Executive Officer Integra LifeSciences Extends Employment Agreement of Chief Executive Officer PLAINSBORO, N.J., July 27, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that Stuart M. Essig, Integra's President and Chief Executive Officer, has renewed his employment	View HTML Integra LifeSciences Extends Employment Agreement of Chief Executive Officer 14.5 KB
Toggle SummaryJul 14, 2004	Integra LifeSciences Schedules Conference Call for Wednesday, July 28 to Discuss Second Quarter 2004 Financial Results and Update Forward-Looking Financial Guidance Integra LifeSciences Schedules Conference Call for Wednesday, July 28 to Discuss Second Quarter 2004 Financial Results and Update Forward-Looking Financial Guidance PLAINSBORO, N.J.--(BUSINESS WIRE)--July 14, 2004--Integra LifeSciences Holdings Corporation (Nasdaq:IART) has scheduled a conference	View HTML Integra LifeSciences Schedules Conference Call for Wednesday, July 28 to Discuss Second Quarter 2004 Financial Results and Update Forward-Looking Financial Guidance 9.2 KB